Stock Quote
Pfizer Inc. (PFEB.BR) (Brussels Stock Exchange)
€12.35
11:27am EST
+2.15%
€12.09
€12.38
13,642
€12.50
€12.11
€13.30
€8.71
0.77
7,515
PFEB.BR
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Kindler, Jeffrey | Chairman of the Board, Chief Executive Officer | 13,770,422 |
| Steere, William | Chairman Emeritus | 2,995,440 |
| D'Amelio, Frank | Chief Financial Officer, Senior Vice President | 8,132,350 |
Profile
Pfizer Inc. (Pfizer) is a research-based, global pharmaceutical company. The Company discovers, develops, manufactures and markets prescription medicines for humans and animals. It operates in two business segments: Pharmaceutical and Animal Health. Pfizer also operates several other businesses,... Full Description
Company Address
Pfizer Inc.
235 East 42nd Street
New York NY 10017
P: +1212.7332323
F: +1212.5737851
235 East 42nd Street
New York NY 10017
P: +1212.7332323
F: +1212.5737851
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| The Procter & Gamble Company | $62.73 | +0.93 |
| Johnson & Johnson | $62.69 | +0.38 |
| GlaxoSmithKline plc | £1,277.50 | +24.00 |
| PFEB.BR | Industry | |
|---|---|---|
| P/E(TTM) | 15.34 | 6.90 |
| P/S(TTM) | 3.23 | 1.54 |
| ROI(TTM) | 7.69 | 6.18 |
| ROE(TTM) | 12.13 | 9.32 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | 0.59 |
| EPS Est. (Current Year) | 2.03 |
| Total Revenue | $11,621.00M |
| Net Income | $2,879.00M |
| EPS | $0.43 |
